» Articles » PMID: 33057179

Wild-type Huntingtin Regulates Human Macrophage Function

Overview
Journal Sci Rep
Specialty Science
Date 2020 Oct 15
PMID 33057179
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The huntingtin (HTT) protein in its mutant form is the cause of the inherited neurodegenerative disorder, Huntington's disease. Beyond its effects in the central nervous system, disease-associated mutant HTT causes aberrant phenotypes in myeloid-lineage innate immune system cells, namely monocytes and macrophages. Whether the wild-type form of the protein, however, has a role in normal human macrophage function has not been determined. Here, the effects of lowering the expression of wild-type (wt)HTT on the function of primary monocyte-derived macrophages from healthy, non-disease human subjects were examined. This demonstrated a previously undescribed role for wtHTT in maintaining normal macrophage health and function. Lowered wtHTT expression was associated, for instance, with a diminished release of induced cytokines, elevated phagocytosis and increased vulnerability to cellular stress. These may well occur by mechanisms different to that associated with the mutant form of the protein, given an absence of any effect on the intracellular signalling pathway predominantly associated with macrophage dysfunction in Huntington's disease.

Citing Articles

Neurodegenerative disorders, metabolic icebergs, and mitohormesis.

Phillips M, Picard M Transl Neurodegener. 2024; 13(1):46.

PMID: 39242576 PMC: 11378521. DOI: 10.1186/s40035-024-00435-8.


Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ-on-a-Chip Technology.

Pramotton F, Spitz S, Kamm R Adv Sci (Weinh). 2024; 11(32):e2403892.

PMID: 38922799 PMC: 11348103. DOI: 10.1002/advs.202403892.


Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions.

Burtscher J, Strasser B, Pepe G, Burtscher M, Kopp M, Di Pardo A Int J Mol Sci. 2024; 25(9).

PMID: 38731912 PMC: 11083237. DOI: 10.3390/ijms25094696.


Gut Microbiota as a Modifier of Huntington's Disease Pathogenesis.

Khoshnan A J Huntingtons Dis. 2024; 13(2):133-147.

PMID: 38728199 PMC: 11307070. DOI: 10.3233/JHD-240012.


Dietary fasting and time-restricted eating in Huntington's disease: therapeutic potential and underlying mechanisms.

Wells R, Neilson L, McHill A, Hiller A Transl Neurodegener. 2024; 13(1):17.

PMID: 38561866 PMC: 10986006. DOI: 10.1186/s40035-024-00406-z.


References
1.
Gervais F, Singaraja R, Xanthoudakis S, Gutekunst C, Leavitt B, Metzler M . Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol. 2002; 4(2):95-105. DOI: 10.1038/ncb735. View

2.
Trager U, Andre R, Magnusson-Lind A, Miller J, Connolly C, Weiss A . Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models. Neurobiol Dis. 2014; 73:388-98. PMC: 4262574. DOI: 10.1016/j.nbd.2014.10.012. View

3.
Miller J, Pfister E, Liu W, Andre R, Trager U, Kennington L . Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells. Sci Rep. 2017; 7:46740. PMC: 5402279. DOI: 10.1038/srep46740. View

4.
Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L . Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003; 35(1):76-83. DOI: 10.1038/ng1219. View

5.
Bates G, Dorsey R, Gusella J, Hayden M, Kay C, Leavitt B . Huntington disease. Nat Rev Dis Primers. 2016; 1:15005. DOI: 10.1038/nrdp.2015.5. View